You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
X Demographics
Mendeley readers
Attention Score in Context
| Title |
Intensive prolonged exposure therapy for combat-related posttraumatic stress disorder: Design and methodology of a randomized clinical trial
|
|---|---|
| Published in |
Contemporary Clinical Trials, July 2018
|
| DOI | 10.1016/j.cct.2018.07.016 |
| Pubmed ID | |
| Authors |
Alan L. Peterson, Edna B. Foa, Tabatha H. Blount, Carmen P. McLean, Dhiya V. Shah, Stacey Young-McCaughan, Brett T. Litz, Richard P. Schobitz, Diane T. Castillo, Timothy O. Rentz, Jeffrey S. Yarvis, Katherine A. Dondanville, Brooke A. Fina, Brittany N. Hall-Clark, Lily A. Brown, Bryann R. DeBeer, Vanessa M. Jacoby, Allison K. Hancock, Douglas E. Williamson, Wyatt R. Evans, Samantha Synett, Casey Straud, Hunter R. Hansen, Eric C. Meyer, Martin A. Javors, Allah-Fard M. Sharrieff, Jose Lara-Ruiz, Lauren M. Koch, John D. Roache, Jim Mintz, Terence M. Keane, for the Consortium to Alleviate PTSD |
| Abstract |
Combat-related posttraumatic stress disorder (PTSD) is the most common psychological health condition in military service members and veterans who have deployed to the combat theater since September 11, 2001. One of the highest research priorities for the Department of Defense and the Department of Veterans Affairs is to develop and evaluate the most efficient and efficacious treatments possible for combat-related PTSD. However, the treatment of combat-related PTSD in military service members and veterans has been significantly more challenging than the treatment of PTSD in civilians. Randomized clinical trials have demonstrated large posttreatment effect sizes for PTSD in civilian populations. However, recent randomized clinical trials of service members and veterans have achieved lesser reductions in PTSD symptoms. These results suggest that combat-related PTSD is unique. Innovative approaches are needed to augment established evidence-based treatments with targeted interventions that address the distinctive elements of combat-related traumas. This paper describes the design, methodology, and protocol of a randomized clinical trial to compare two intensive prolonged exposure therapy treatments for combat-related PTSD in active duty military service members and veterans and that can be administered in an acceptable, efficient manner in this population. Both interventions include intensive daily treatment over a 3-week period and a number of treatment enhancements hypothesized to result in greater reductions in combat-related PTSD symptoms. The study is designed to advance the delivery of care for combat-related PTSD by developing and evaluating the most potent treatments possible to reduce PTSD symptomatology and improve psychological, social, and occupational functioning. |
X Demographics
The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 1 | 100% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Scientists | 1 | 100% |
Mendeley readers
The data shown below were compiled from readership statistics for 67 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 67 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Master | 9 | 13% |
| Researcher | 7 | 10% |
| Student > Bachelor | 6 | 9% |
| Student > Doctoral Student | 4 | 6% |
| Student > Postgraduate | 3 | 4% |
| Other | 11 | 16% |
| Unknown | 27 | 40% |
| Readers by discipline | Count | As % |
|---|---|---|
| Psychology | 15 | 22% |
| Nursing and Health Professions | 7 | 10% |
| Medicine and Dentistry | 3 | 4% |
| Pharmacology, Toxicology and Pharmaceutical Science | 3 | 4% |
| Social Sciences | 3 | 4% |
| Other | 8 | 12% |
| Unknown | 28 | 42% |
Attention Score in Context
This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 15 August 2018.
All research outputs
#20,663,600
of 25,385,509 outputs
Outputs from Contemporary Clinical Trials
#1,598
of 1,967 outputs
Outputs of similar age
#265,243
of 341,271 outputs
Outputs of similar age from Contemporary Clinical Trials
#16
of 20 outputs
Altmetric has tracked 25,385,509 research outputs across all sources so far. This one is in the 10th percentile – i.e., 10% of other outputs scored the same or lower than it.
So far Altmetric has tracked 1,967 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 7.6. This one is in the 8th percentile – i.e., 8% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 341,271 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 12th percentile – i.e., 12% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 20 others from the same source and published within six weeks on either side of this one. This one is in the 10th percentile – i.e., 10% of its contemporaries scored the same or lower than it.